Navigation Links
FDA Approves New Mechanism of Action Labeling for Ranexa(R)
Date:12/18/2007

Therapeutics' approved product, Ranexa(R) (ranolazine extended-release tablets), is indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

CV Therapeutics' clinical and preclinical drug development candidates and programs include regadenoson, which is being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies, and CVT-6883, which is being developed as a potential treatment for cardiopulmonary diseases. Regadenoson and CVT-6883 have not been determined by any regulatory authorities to be safe or effective in humans for any use.

Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including operating losses and fluctuations in operating results; capital requirements; regulatory review and approval of our products; special protocol assessment agreement; the conduct and timing of clinical trials; commercialization of products; market acceptance of products; product labeling; concentrated customer base; reliance on strategic partnerships and collaborations; uncertainties in drug development; uncertainties regarding intellectual property; and other risks detailed from time to time in CV Therapeutics' SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. CV Therapeutics disclaims any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Corporation, an innovator of advanced optical instruments, announced ... with Harvard University granting Nikon the rights to ... Under the terms of the agreement, Nikon will ... with the N-STORM name. ,, Nikon Corporation ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... their health at home through the merger of rapid diagnostics ... share on its Series B Convertible Perpetual Preferred Stock ( ... B stock in an amount per share equal to the ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Neurostimulation - A Global ... ,, The world neurostimulation market stands ... population, and the resultant rise in age-related ...
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... (OTC Bulletin Board: DORB) (DOR or the Company), a ... 2008. DOR,s revenues for 2008 were approximately $2.3 million ... was due primarily to progress with DOR,s September 2006 ... and development milestones with our subcontractors. DOR,s net loss ...
... - Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll ... CollaRx(TM) Lidocaine Sponge for the management of painful wounds. ... patients worldwide suffer from chronic wounds (venous stasis ulcers, ... of all chronic wounds do not heal within 5 ...
... Even HealthierST. LOUIS, March 31 Recent research reveals ... be beneficial to the diet. And, the majority recognizes ... such as soyfoods even healthier. These findings come from ... - sponsored by the United Soybean Board (USB) ...
Other Biology Technology:DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 5Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 3
(Date:12/5/2009)... could become the source of more of humanity,s food ... aquaculture, according to a study published in the December ... world,s population continues to grow, lack of fresh water ... be able to meet food demand, according to Carlos ... Spain, and his seven coauthors. Freshwater aquaculture, which is ...
(Date:12/4/2009)... statewide data taken from 1998-2001, women in Oregon who ... three times likely to report they were discriminated against ... pregnancy and delivery. , In addition, reporting of ... mothers with Medicaid coverage, and four times more likely ...
(Date:12/4/2009)... . , A new study of the Max ... the positive effect of dietary restriction on healthy ageing. Previous ... that dietary restriction increases longevity, but with a potential negative ... reproduces less frequently with a reduced litter size on a ...
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How nutrition affects healthy aging 2Reportlinker Adds North America Air Purification Equipment Market Report 56779 1Reportlinker Adds North America Air Purification Equipment Market Report 56779 2Reportlinker Adds North America Air Purification Equipment Market Report 56779 3Reportlinker Adds North America Air Purification Equipment Market Report 56779 4Reportlinker Adds North America Air Purification Equipment Market Report 56779 5Reportlinker Adds North America Air Purification Equipment Market Report 56779 6Reportlinker Adds North America Air Purification Equipment Market Report 56779 7Reportlinker Adds North America Air Purification Equipment Market Report 56779 8Reportlinker Adds North America Air Purification Equipment Market Report 56779 9Reportlinker Adds North America Air Purification Equipment Market Report 56779 10Reportlinker Adds North America Air Purification Equipment Market Report 56779 11Reportlinker Adds North America Air Purification Equipment Market Report 56779 12Reportlinker Adds North America Air Purification Equipment Market Report 56779 13Reportlinker Adds North America Air Purification Equipment Market Report 56779 14Reportlinker Adds North America Air Purification Equipment Market Report 56779 15VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 56774 1VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 56774 2VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 56774 3VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 56774 4VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 56774 5Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 1Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 2Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 3Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 4Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 5Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 6Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 7Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 8Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 9Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 10Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 11Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 12Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 13Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 14Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 15Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 16Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 17Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 18
... temperatures to increase in Hawaii,s mountains, deadly non-native ... mountains, invading most of the last disease-free refuges ... remarkable birds. , A just-published U.S. Geological ... forthcoming "disease invasion" by examining the present altitudinal ...
... Scientists from around the world will convene at the ... key findings from the most ambitious effort ever undertaken ... determine how they contribute in the near term to ... , The two-year international field campaign known as POLARCAT ...
... Netherlands, May 26, 2009 There are several risk ... dementia. Based on an increasing number of studies linking ... in the current issue of the Journal of ... PhD of the Sunlight, Nutrition, and Health Research Center ...
Other Biology News:Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia? 2
...
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
Lipid-rich bovine serum albumin for cell culture. It is chromatographically purified and has an IgG content 1.0% (w/w)....
Biology Products: